Description:

CALGB COOPERATIVE GROUP ADJUVANT BREAST CANCER RANDOMIZATION NCT00016276 Combination Chemotherapy, Surgery, and Radiation Therapy With or Without Dexrazoxane and Trastuzumab in Treating Women With Stage III or Stage IV Breast Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=9E35395C-8542-227A-E034-080020C9C0E0

Link:

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=9E35395C-8542-227A-E034-080020C9C0E0

Keywords:
Versions (4) ▾
  1. 8/26/12
  2. 5/22/15
  3. 6/3/15
  4. 9/20/21
Uploaded on:

September 20, 2021

DOI:
No DOI assigned. To request one please log in.
License:
Creative Commons BY-NC 3.0 Legacy
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

CALGB COOPERATIVE GROUP ADJUVANT BREAST CANCER RANDOMIZATION NCT00016276

Details

No Instruction available.

  1. StudyEvent: CALGB COOPERATIVE GROUP ADJUVANT BREAST CANCER RANDOMIZATION
    1. No Instruction available.
CALGB Information
Protocol Administration
Patient Demographics / Pre U Treatment Characteristics
Patient Race/ Ethnicity
8 more items in the detailed view.
Sex
Method of Payment
4 more items in the detailed view.
Zip Code
Performance Status
Patient Eligible?
Stratification Factors
Disease Type
Patient?s initial consent given for specimen use for research on the patient?s cancer?
Patient?s initial consent given for specimen use for research unrelated to the patient?s cancer?
Patient?s initial consent given for further contact regarding specimen?
Back to the top of the page 

Similar models